Q2 2015 Holdings
Filed 2015-08-14 | 120 holdings | $97.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $43.0M | 611,436 | 44.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $24.9M | 1,405,348 | 25.5% |
| Axogen Inc(AXGN) | COM | 05463X106 | $11.7M | 3,726,439 | 12.0% |
| Amphastar Pharmaceuticals in(AMPH) | COM | 03209R103 | $7.9M | 448,532 | 8.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $5.4M | 690,538 | 5.5% |
| Caredx Inc(CDNA) | COM | 14167L103 | $1.5M | 229,000 | 1.5% |
| Horizon Pharma PLC | SHS | G4617B105 | $425.9K | 12,259,875 | 0.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $369.0K | 20,859 | 0.4% |
| Allscripts Healthcare Solutn | NOTE 1.250% 7/0 | 01988PAD0 | $103.5K | $100,750,000 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $86.3K | 4,072,809 | 0.1% |
| Nxstage Medical Inc | COM | 67072V103 | $82.5K | 5,773,050 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $68.7K | 9,529,361 | 0.1% |
| Dyax Corp | COM | 26746E103 | $65.8K | 2,483,507 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $60.7K | 4,784,157 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $59.1K | 871,000 | 0.1% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $57.3K | 1,376,722 | 0.1% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $56.9K | $45,000,000 | 0.1% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $56.5K | 3,732,412 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $55.0K | 326,783 | 0.1% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $54.8K | 648,501 | 0.1% |
| Davita Healthcare Partners I(DVA) | COM | 23918K108 | $50.5K | 636,000 | 0.1% |
| Aetna Inc New | COM | 00817Y108 | $47.1K | 369,739 | 0.0% |
| Universal Amern Corp New | COM | 91338E101 | $44.6K | 4,409,703 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $44.5K | 361,953 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $41.4K | 3,264,588 | 0.0% |
| Endologix Inc | NOTE 2.250%12/1 | 29266SAA4 | $39.8K | $40,941,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $39.0K | 2,211,644 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $38.3K | 18,389,789 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $38.2K | 646,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $38.0K | 631,192 | 0.0% |
| Spectranetics Corp | MTNF 2.625% 6/0 | 84760CAA5 | $38.0K | $36,901,000 | 0.0% |
| Endologix Inc | COM | 29266S106 | $37.6K | 2,449,897 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $34.9K | 1,007,614 | 0.0% |
| Adeptus Health Inc(ADPTEUR) | CL A | 006855100 | $34.6K | 364,000 | 0.0% |
| Heartware Intl Inc | NOTE 3.500%12/1 | 422368AA8 | $33.2K | $31,264,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $33.1K | 642,608 | 0.0% |
| Genomic Health Inc(GHDX) | COM | 37244C101 | $32.9K | 1,183,000 | 0.0% |
| Arena Pharmaceuticals Inc | COM | 040047102 | $32.4K | 6,983,710 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $31.0K | 1,411,000 | 0.0% |
| Fluidigm Corp del | NOTE 2.750% 2/0 | 34385PAA6 | $31.0K | $35,000,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $30.6K | 136,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $30.2K | 211,850 | 0.0% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $30.0K | 1,016,453 | 0.0% |
| Healthways Inc | COM | 422245100 | $29.5K | 2,465,042 | 0.0% |
| Endochoice Hldgs Inc | COM | 29272U103 | $29.4K | 1,797,709 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $27.0K | 2,465,129 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $26.8K | 601,772 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $26.1K | 1,450,151 | 0.0% |
| Healthways Inc | NOTE 1.500% 7/0 | 422245AB6 | $25.9K | $27,915,000 | 0.0% |
| Webmd Health Corp | NOTE 1.500%12/0 | 94770VAK8 | $24.6K | $23,000,000 | 0.0% |